MARKET

BMY

BMY

Bristol-Myers
NYSE

Real-time Quotes | Nasdaq Last Sale

63.82
-0.12
-0.19%
After Hours: 63.55 -0.27 -0.42% 17:04 12/13 EST
OPEN
64.04
PREV CLOSE
63.94
HIGH
64.75
LOW
63.79
VOLUME
14.53M
TURNOVER
--
52 WEEK HIGH
64.75
52 WEEK LOW
42.48
MARKET CAP
149.61B
P/E (TTM)
18.44
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BMY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BMY News

  • Bristol-Myers prevails over Gilead in Yescarta royalty row - Bloomberg Law
  • Reuters.2h ago
  • Bristol-Myers Squibb Wins Patent Royalty Fight Against Gilead; Co. Awarded $585M In Damages Plus Royalty
  • Bloomberg.2h ago
  • European advisory group backs generic version of Celgene's Vidaza
  • seekingalpha.4h ago
  • Simple Secrets Anyone Can Use to Reach Early Retirement - December 13, 2019
  • Zacks.8h ago

More

Industry

Pharmaceuticals
+0.14%
Pharmaceuticals & Medical Research
-0.08%

Hot Stocks

Name
Price
%Change

About BMY

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. The Company’s subsidiary is Celgene Corp.
More

Webull offers Bristol-Myers Squibb Co (BMY) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.